Gut hormones' regulation of fat production abnormal in obesity, fatty liver disease: study


By Xu Jing

CHICAGO, Nov. 24 (Xinhua) -- One key gut hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver. This regulation is abnormal in obesity, according to a study posted on the website of the University of Illinois (UI) on Tuesday.

In the study, the researchers found that the gut hormone FGF15 in mice and its human counterpart FGF19 turn off fat-producing genes in the liver. The hormones are released a few hours after eating, when the body transitions from feeding to fasting. FGF15/19 activate regulatory molecules to enter the nucleus, the center of the cell where DNA is stored, and inhibit gene expression.

"This gut hormone actually acts as a breaker of insulin action, and specifically inhibits lipogenesis in the liver so that it's tightly regulated," said UI molecular and integrative physiology professor Jongsook Kim Kemper. "For example, with the holidays coming up, if you eat some cookies, the body will release insulin, which promotes lipogenesis. If lipogenesis is not reduced later when the body enters the fasting state, excess fat will accumulate in the liver, so the FGF19 hormone puts the brakes on fat production."

Furthermore, in experiments involving mice with obesity and human patients with nonalcoholic fatty liver disease, the researchers found that the pathway for turning off fat production was dysregulated. The genes that the gut hormone regulates were highly active, the FGF15/19-activated regulatory molecules did not even enter the cell's nucleus and the suppression markers were not added to the genes.

"This study could be very important for understanding this pathway and investigating how it is abnormal in obesity and nonalcoholic fatty liver disease," Kemper said. "It adds to our understanding of obesity, nonalcoholic fatty liver disease and other metabolic disorders. It also could have implications for other diseases such as diabetes or certain cancers, for which obesity is a risk factor.

"Based on this study, we potentially could search for therapeutic treatment options to target this pathway and increase regulatory function."

The study has been published in the journal Nature Communications.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In World

COVID-19 vaccine delays may slow wider Irish roll-out, says PM
Poland appeals to Britain to repatriate man in vegetative state
Saudi Arabia expects 'excellent relations' with Biden administration
Larry King, decades-long fixture of U.S. TV interviews, dead at 87
Veteran TV talk show host Larry King dies
Iran's Zarif open to oil, Gulf security contacts with U.S., not on Israel
French health body recommends delaying second COVID shot to six weeks after first
Police detain ally of Kremlin critic Navalny at Moscow rally
Taiwan reports large incursion by Chinese air force
Wife stabs husband after seeing her younger self in old photos, thought he was cheating

Stories You'll Enjoy